과제정보
This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2019M3E5D3073568 and NRF-2021R1A4A1029097 to J.Y.A.) and Korea University to J.Y.A. E.H.C. received a scholarship from the Kwanjeong Educational Foundation and the Brain Korea (BK21) FOUR education program.
참고문헌
- Bielski CM, Zehir A, Penson AV et al (2018) Genome doubling shapes the evolution and prognosis of advanced cancers. Nat Genet 50, 1189-1195 https://doi.org/10.1038/s41588-018-0165-1
- Quinton RJ, DiDomizio A, Vittoria MA et al (2021) Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature 590, 492-497 https://doi.org/10.1038/s41586-020-03133-3
- Gillette MA, Satpathy S, Cao S et al (2020) Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182, 200-225 e235
- Dewhurst SM, McGranahan N, Burrell RA et al (2014) Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov 4, 175-185 https://doi.org/10.1158/2159-8290.CD-13-0285
- Lopez S, Lim EL, Horswell S et al (2020) Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution. Nat Genet 52, 283-293 https://doi.org/10.1038/s41588-020-0584-7
- Ganem NJ and Pellman D (2007) Limiting the proliferation of polyploid cells. Cell 131, 437-440 https://doi.org/10.1016/j.cell.2007.10.024
- Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT and Pellman D (2005) Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437, 1043-1047 https://doi.org/10.1038/nature04217
- Ganem NJ, Cornils H, Chiu SY et al (2014) Cytokinesis failure triggers hippo tumor suppressor pathway activation. Cell 158, 833-848 https://doi.org/10.1016/j.cell.2014.06.029
- Senovilla L, Vitale I, Martins I et al (2012) An immunosurveillance mechanism controls cancer cell ploidy. Science 337, 1678-1684 https://doi.org/10.1126/science.1224922
- Andreassen PR, Lohez OD, Lacroix FB and Margolis RL (2001) Tetraploid state induces p53-dependent arrest of non-transformed mammalian cells in G1. Mol Biol Cell 12, 1315-1328 https://doi.org/10.1091/mbc.12.5.1315
- Sanz-Gomez N, Gonzalez-Alvarez M, De Las Rivas J and de Carcer G (2023) Whole-genome doubling as a source of cancer: how, when, where, and why? Front Cell Dev Biol 11, 1209136
- Davoli T, Denchi EL and de Lange T (2010) Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 141, 81-93 https://doi.org/10.1016/j.cell.2010.01.031
- Jeong HC, Gil NY, Lee HS et al (2015) Timely degradation of Wip1 phosphatase by APC/C activator protein Cdh1 is necessary for normal mitotic progression. J Cell Biochem 116, 1602-1612 https://doi.org/10.1002/jcb.25114
- Zeng J, Hills SA, Ozono E and Diffley JFX (2023) Cyclin E-induced replicative stress drives p53-dependent whole-genome duplication. Cell 186, 528-542 e514
- Brito DA and Rieder CL (2006) Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol 16, 1194-1200 https://doi.org/10.1016/j.cub.2006.04.043
- Shi Q and King RW (2005) Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 437, 1038-1042 https://doi.org/10.1038/nature03958
- Duelli DM, Padilla-Nash HM, Berman D, Murphy KM, Ried T and Lazebnik Y (2007) A virus causes cancer by inducing massive chromosomal instability through cell fusion. Curr Biol 17, 431-437 https://doi.org/10.1016/j.cub.2007.01.049
- Overholtzer M, Mailleux AA, Mouneimne G et al (2007) A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131, 966-979 https://doi.org/10.1016/j.cell.2007.10.040
- Krajcovic M, Johnson NB, Sun Q et al (2011) A non-genetic route to aneuploidy in human cancers. Nat Cell Biol 13, 324-330 https://doi.org/10.1038/ncb2174
- Gjelsvik KJ, Besen-McNally R and Losick VP (2019) Solving the polyploid mystery in health and disease. Trends Genet 35, 6-14 https://doi.org/10.1016/j.tig.2018.10.005
- Edgar BA, Zielke N and Gutierrez C (2014) Endocycles: a recurrent evolutionary innovation for post-mitotic cell growth. Nat Rev Mol Cell Biol 15, 197-210 https://doi.org/10.1038/nrm3756
- Duncan AW, Taylor MH, Hickey RD et al (2010) The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 467, 707-710 https://doi.org/10.1038/nature09414
- Al-Rawi DH and Bakhoum SF (2022) Chromosomal instability as a source of genomic plasticity. Curr Opin Genet Dev 74, 101913
- Olaharski AJ, Sotelo R, Solorza-Luna G et al (2006) Tetra-ploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 27, 337-343 https://doi.org/10.1093/carcin/bgi218
- Song S, Jung S and Kwon M (2023) Expanding roles of centrosome abnormalities in cancers. BMB Rep 56, 216-224 https://doi.org/10.5483/BMBRep.2023-0025
- King RW (2008) When 2+2=5: the origins and fates of aneuploid and tetraploid cells. Biochim Biophys Acta 1786, 4-14 https://doi.org/10.1016/j.bbcan.2008.07.007
- Coward J and Harding A (2014) Size does matter: why polyploid tumor cells are critical drug targets in the war on cancer. Front Oncol 4, 123
- Zhang J, Qiao Q, Xu H, Zhou R and Liu X (2022) Human cell polyploidization: the good and the evil. Semin Cancer Biol 81, 54-63 https://doi.org/10.1016/j.semcancer.2021.04.005
- Lambuta RA, Nanni L, Liu Y et al (2023) Whole-genome doubling drives oncogenic loss of chromatin segregation. Nature 615, 925-933 https://doi.org/10.1038/s41586-023-05794-2
- Gemble S, Wardenaar R, Keuper K et al (2022) Genetic instability from a single S phase after whole-genome duplication. Nature 604, 146-151 https://doi.org/10.1038/s41586-022-04578-4
- Andreassen PR, Lacroix FoB, Lohez OD and Margolis RL (2001) Neither p21WAF1 nor 14-3-3σ prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells. Cancer Res 61, 7660-7668
- Jo Y and Shin DY (2017) Repression of the F-box protein Skp2 is essential for actin damage-induced tetraploid G1 arrest. BMB Rep 50, 379-383 https://doi.org/10.5483/BMBRep.2017.50.7.063
- Aylon Y, Ofir-Rosenfeld Y, Yabuta N et al (2010) The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Genes Dev 24, 2420-2429 https://doi.org/10.1101/gad.1954410
- Carter SL, Cibulskis K, Helman E et al (2012) Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 30, 413-421 https://doi.org/10.1038/nbt.2203
- Taylor AM, Shih J, Ha G et al (2018) Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33, 676-689 e673
- Steele CD, Abbasi A, Islam SMA et al (2022) Signatures of copy number alterations in human cancer. Nature 606, 984-991 https://doi.org/10.1038/s41586-022-04738-6
- Shen R and Seshan VE (2016) FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res 44, e131
- Priestley P, Baber J, Lolkema MP et al (2019) Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210-216 https://doi.org/10.1038/s41586-019-1689-y
- Cameron DL, Baber J, Shale C et al (2019) GRIDSS, PURPLE, LINX: unscrambling the tumor genome via integrated analysis of structural variation and copy number. BioRxiv, 781013
- Frankell AM, Dietzen M, Al Bakir M et al (2023) The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 616, 525-533 https://doi.org/10.1038/s41586-023-05783-5
- Offin M, Chan JM, Tenet M et al (2019) Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes. J Thorac Oncol 14, 1784-1793 https://doi.org/10.1016/j.jtho.2019.06.002
- Zhang T, Joubert P, Ansari-Pour N et al (2021) Genomic and evolutionary classification of lung cancer in never smokers. Nat Genet 53, 1348-1359 https://doi.org/10.1038/s41588-021-00920-0
- Nahar R, Zhai W, Zhang T et al (2018) Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing. Nat Commun 9, 216
- De Bruin EC, McGranahan N, Mitter R et al (2014) Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251-256 https://doi.org/10.1126/science.1253462
- Choudhary A, Zachek B, Lera RF et al (2016) Identification of selective lead compounds for treatment of high-ploidy breast cancer. Mol Cancer Ther 15, 48-59 https://doi.org/10.1158/1535-7163.MCT-15-0527
- Newcomb R, Dean E, McKinney BJ and Alvarez JV (2021) Context-dependent effects of whole-genome duplication during mammary tumor recurrence. Sci Rep 11, 14932
- Minussi DC, Nicholson MD, Ye H et al (2021) Breast tumours maintain a reservoir of subclonal diversity during expansion. Nature 592, 302-308 https://doi.org/10.1038/s41586-021-03357-x
- Berenjeno IM, Pineiro R, Castillo SD et al (2017) Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling. Nat Commun 8, 1773
- Yates LR, Knappskog S, Wedge D et al (2017) Genomic evolution of breast cancer metastasis and relapse. Cancer Cell 32, 169-184 e167
- Guinney J, Dienstmann R, Wang X et al (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21, 1350-1356 https://doi.org/10.1038/nm.3967
- Kim JE, Choi J, Sung CO et al (2021) High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer. Exp Mol Med 53, 446-456 https://doi.org/10.1038/s12276-021-00583-1
- Cohen-Sharir Y, McFarland JM, Abdusamad M et al (2021) Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition. Nature 590, 486-491 https://doi.org/10.1038/s41586-020-03114-6
- Kabel J, Henriksen TV, Demuth C et al (2023) Impact of whole genome doubling on detection of circulating tumor DNA in colorectal cancer. Cancers 15, 1136
- Vigano C, von Schubert C, Ahrne E et al (2018) Quantitative proteomic and phosphoproteomic comparison of human colon cancer DLD-1 cells differing in ploidy and chromosome stability. Mol Biol Cell 29, 1031-1047 https://doi.org/10.1091/mbc.E17-10-0577
- Chan-Seng-Yue M, Kim JC, Wilson GW et al (2020) Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat Genet 52, 231-240 https://doi.org/10.1038/s41588-019-0566-9
- Sakamoto H, Attiyeh MA, Gerold JM et al (2020) The evolutionary origins of recurrent pancreatic cancer. Cancer Discov 10, 792-805 https://doi.org/10.1158/2159-8290.CD-19-1508
- Notta F, Chan-Seng-Yue M, Lemire M et al (2016) A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature 538, 378-382 https://doi.org/10.1038/nature19823
- Baslan T, Morris JPt, Zhao Z et al (2022) Ordered and deterministic cancer genome evolution after p53 loss. Nature 608, 795-802 https://doi.org/10.1038/s41586-022-05082-5
- Lopez-Gines C, Gil-Benso R, Ferrer-Luna R et al (2010) New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile. Mod Pathol 23, 856-865 https://doi.org/10.1038/modpathol.2010.62
- Hadi K, Yao X, Behr JM et al (2020) Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs. Cell 183, 197-210 e132
- Furgason JM, Koncar RF, Michelhaugh SK et al (2015) Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma. Oncoscience 2, 618
- Castro MP, Khanlou N, Fallah A et al (2022) Targeting chromosome 12q amplification in relapsed glioblastoma: the use of computational biological modeling to identify effective therapy-a case report. Ann Transl Med 10, 1289
- Walentynowicz KA, Engelhardt D, Cristea S et al (2023) Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma. Cell Rep 42, 112235
- Favero F, McGranahan N, Salm M et al (2015) Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome. Ann Oncol 26, 880-887 https://doi.org/10.1093/annonc/mdv127
- Heo YJ, Hwa C, Lee GH, Park JM and An JY (2021) Integrative multi-omics approaches in cancer research: from biological networks to clinical subtypes. Mol Cells 44, 433-443 https://doi.org/10.14348/molcells.2021.0042
- Satpathy S, Krug K, Jean Beltran PM et al (2021) A proteogenomic portrait of lung squamous cell carcinoma. Cell 184, 4348-4371 e4340
- Krug K, Jaehnig EJ, Satpathy S et al (2020) Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy. Cell 183, 1436-1456 e1431
- Huang C, Chen L, Savage SR et al (2021) Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer Cell 39, 361-379 e316
- Dou Y, Kawaler EA, Cui Zhou D et al (2020) Proteogenomic characterization of endometrial carcinoma. Cell 180, 729-748 e726
- Cao L, Huang C, Cui Zhou D et al (2021) Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell 184, 5031-5052 e5026
- Wang LB, Karpova A, Gritsenko MA et al (2021) Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell 39, 509-528 e520
- Vasaikar S, Huang C, Wang X et al (2019) Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell 177, 1035-1049 e1019
- Tarantino G, Ricker CA, Wang A et al (2022) Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma. BioRxiv, 2022.2012. 2011.519808
- Alexandrov LB, Kim J, Haradhvala NJ et al (2020) The repertoire of mutational signatures in human cancer. Nature 578, 94-101 https://doi.org/10.1038/s41586-020-1943-3